The Financial Cost of Commercialization Readiness

Overview

As life sciences companies move toward commercialization, systems and processes built for clinical-stage operations can quickly become financial and operational risks.

Join STAEDEAN for a Lunch & Learn on where these risks emerge, what delaying operational readiness can cost, and how to prepare for commercialization before growth adds complexity.

This event is designed for life sciences leaders across finance, IT, supply chain, quality, and commercialization.

Topics to be Discussed

• The financial risks of fragmented operations
• Working capital, margin, and forecasting visibility
• Supply chain and compliance readiness
• The cost of delaying operational readiness

Register
Date
-
Address

NCBiotech
15 TW Alexander Dr.
Durham, NC 27713

Cost
No Cost
Tags
Contract Service Organizations
Register
scroll back to top of page